FCX-007: Phase I/II started

Fibrocell began an open-label Phase I/II trial to evaluate FCX-007

Read the full 100 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE